Tag: next-generation sequencing in oncology

A retrospective US cohort of 2,694 pancreatic cancer patients found MTAP deletion in 30.5 percent of tumors and consistently lower ...

A 46-year-old woman's uterine tumor resisted classification until two surgeries, immunohistochemistry, and next-generation sequencing excluded Ewing's sarcoma and revealed an ...

A new review outlines how drug-tolerant persister cells hidden within minimal residual disease drive cancer relapse and how pathway inhibitors, ...

As the landscape of precision cancer medicine continues to evolve, the integration of advanced data analytics and machine learning is ...

In the realm of oncology, the classification and treatment of pancreatic cancer has long posed significant challenges to researchers and ...

In a groundbreaking study published in BMC Cancer, researchers from Taiwan have leveraged next-generation sequencing (NGS) technology to unlock the ...

In a groundbreaking advancement poised to reshape the landscape of breast cancer treatment, researchers have harnessed the power of next-generation ...

Acute myeloid leukemia (AML) stands as the most prevalent form of acute leukemia afflicting adults, characterized by its rapid onset ...

In a groundbreaking study that delves into the complex epigenetic landscape of multiple myeloma (MM), researchers have identified critical modifications ...

The advent of immunotherapy has revolutionized the treatment landscape for lung cancer, offering new hope to patients through harnessing the ...